They need to become cash flow +ve for devices and +ve clinical trial results.Until then SP will remain where it is.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
